Indian CDMO Navin Molecular has begun the construction of a new USD $1.2m R&D facility at its site in Dewas, India.
The new laboratory will be situated at its existing site — increasing the company's capacity for laboratory- and kilo-scale process development.
It will also bolster the company's testing and analytical capacity, allowing it to better support its customers in the development and scale-up of their small molecule projects.
New facility promotes efficient chemical handling
According to Navin Molecular, the specialised technology installed into the facility will be capable of handling a wide range of hazardous chemistries.
48 fume hoods, which have been designed to carry out flow reactions and ozonolysis, will be allocated specifically for chemical process development.
A new kilo-scale lab will also be built, with cylindrical vessels of up to 100 L in volume situated on the site to mimic production plant conditions — allowing customers the opportunity to manufacture non-GMP material batches for pre-clinical toxicology screening.
An additional analytical laboratory will also be built, which will support method validation and technological transfer within a project.
Work on the facility began in December 2024, with the project likely being finished in May 2025 — resulting in the doubling of its current R&D team though the creation of 65 new job roles.
“Robust and thorough process development is crucial to ensure the chance of successful scale up, and customers are looking for partners that are flexible and have the capacity to take on projects with the minimum of delay to meet their demanding timelines,” said Jordi Robinson, Chief Commercial Officer at Navin Molecular.
“This expansion will ensure that we can match these expectations, as well as increasing our technology offering through flow chemistry and ozonolysis, ensuring that we can continue to provide the highest quality, cost-effective manufacturing solutions for our customers.”